Howard Marks - Oaktree Capital Management
Holding/activity history for Indivior Pharmaceuticals Inc. (INDV)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 6,984,102 | 4.94 | Reduce 1.75% | 0.10 | $30.48 | $212,875,428 | SEC |
| 2025 Q4 | 7,108,644 | 5.62 | Reduce 97.24% | 0.22 | $35.88 | $255,058,964 | SEC |
| 2025 Q3 | 257,785,398 | 0.23 | Add 2,241.56% | 0.22 | $0.04 | $10,692,053 | SEC |
| 2025 Q2 | 11,009,125 | 4.11 | $14.74 | $162,274,503 | SEC | ||
| 2025 Q1 | 11,009,125 | 2.56 | Add 26.06% | 0.53 | $9.40 | $103,450,915 | SEC |
| 2024 Q4 | 8,733,548 | 2.50 | Reduce 8.28% | 0.15 | $12.82 | $112,004,050 | SEC |
| 2024 Q3 | 9,521,980 | 1.77 | Add 111.92% | 0.93 | $9.88 | $94,068,047 | SEC |
| 2024 Q2 | 4,493,173 | 1.34 | Add 34.08% | 0.34 | $15.67 | $70,429,767 | SEC |
| 2024 Q1 | 3,351,236 | 1.26 | Buy | 1.26 | $21.40 | $71,714,624 | SEC |